• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS ELECSYS RUBELLA IGG; ENZYME LINKED IMMUNOABSORBENT ASSAY, RUBELLA

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS ELECSYS RUBELLA IGG; ENZYME LINKED IMMUNOABSORBENT ASSAY, RUBELLA Back to Search Results
Catalog Number 04618793190
Device Problem High Test Results (2457)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 09/05/2023
Event Type  malfunction  
Event Description
The initial reporter questioned a discrepant positive result for 1 patient sample tested for elecsys rubella igg (rubella igg) on a cobas e 411 analyzer (rack system) compared to a competitor method.The result from the e411 analyzer was 35.23 iu/ml (positive).The sample was tested at a different laboratory using a competitor method where the rubella igg result was negative.
 
Manufacturer Narrative
The e411 analyzer serial number was (b)(6).The competitor method is abbott.Calibration was last performed on (b)(6) 2023 with acceptable results, however, the customer may not be following the recommendations for calibration frequency per the product labeling.Product labeling states: "renewed calibration is recommended as follows: after 1 month (28 days) when using the same reagent lot after 7 days (when using the same reagent kit on the analyzer) as required: e.G.Quality control findings outside the defined limits" the qc data provided shows results for a level 1 control material that expired in apr-2023.The results were acceptable, however, it is not clear on what date the controls were run.Product labeling states: "controls for the various concentration ranges should be run individually at least once every 24 hours when the test is in use, once per reagent kit, and following each calibration." the pre-analytical information provided was acceptable.The sample was received for investigation.The sample was tested with rubella igg reagent lot 707955 and rubella igm reagent lot 707966 on a cobas e411 analyzer.The customer¿s rubella igg result was reproduced during the investigation (39.75 iu/ml).The rubella igm result was 0.244 coi (negative).The investigation is ongoing.
 
Manufacturer Narrative
The sample underwent further investigation by mikrogen blot and an in-house neutralization method.The mikrogen blot result was negative with a small band for the e1 antigen-band potentially showing the presence of low-level anti-e1 antibodies.The neutralization method results show the presence of specific anti-rubella igg antibodies.Based on the investigation results, the elecsys rubella igg result was determined to be correctly positive.The investigation did not identify a product problem.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELECSYS RUBELLA IGG
Type of Device
ENZYME LINKED IMMUNOABSORBENT ASSAY, RUBELLA
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhofer strasse 116
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
amy nelson
9115 hague road
indianapolis, IN 46250
MDR Report Key17968897
MDR Text Key326086978
Report Number1823260-2023-03361
Device Sequence Number1
Product Code LFX
Combination Product (y/n)Y
Reporter Country CodeIT
PMA/PMN Number
K072617
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 11/22/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date02/29/2024
Device Catalogue Number04618793190
Device Lot Number707955
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 09/26/2023
Initial Date FDA Received10/19/2023
Supplement Dates Manufacturer Received11/14/2023
Supplement Dates FDA Received11/22/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Age34 YR
Patient SexFemale
-
-